Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
TScan Therapeutics Inc.
Director · Chief Executive Officer
Rocket Pharmaceuticals Inc.
Director
Chief executive roles
TScan Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 3, 2025 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| May 8, 2024 | PTC Therapeutics Inc. | Gift | −1,650 | — | — |
| May 2, 2024 | Rocket Pharmaceuticals Inc. | Gift | −113,124 | — | — |
| May 2, 2024 | Rocket Pharmaceuticals Inc. | Gift | −59,716 | — | — |
| Apr 15, 2024 | Rocket Pharmaceuticals Inc. | Option exercise | +29,624 | $4.34 | $128,568 |
| Apr 15, 2024 | Rocket Pharmaceuticals Inc. | Open-market sale | −10,000 | $24.05 | $240,500 |
| Apr 12, 2024 | Rocket Pharmaceuticals Inc. | Option exercise | +70,000 | $4.34 | $303,800 |
| Apr 12, 2024 | Rocket Pharmaceuticals Inc. | Open-market sale | −59,716 | $24.22 | $1,446,322 |
| Apr 12, 2024 | Rocket Pharmaceuticals Inc. | Open-market sale | −10,284 | $25.16 | $258,745 |
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Apr 17, 2023 | PTC Therapeutics Inc. | Option exercise | +11,429 | $18.01 | $205,836 |
| Apr 17, 2023 | PTC Therapeutics Inc. | Open-market sale | −6,241 | $50.69 | $316,356 |
| Apr 17, 2023 | PTC Therapeutics Inc. | Open-market sale | −5,188 | $51.43 | $266,819 |
| Mar 31, 2023 | PTC Therapeutics Inc. | Option exercise | +2,571 | $18.01 | $46,304 |
| Mar 31, 2023 | PTC Therapeutics Inc. | Open-market sale | −2,571 | $50.05 | $128,679 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.